Session » Reproductive Issues in Rheumatic Disorders Poster

Date: Tuesday, October 23, 2018

Time: 9:00AM-11:00AM

Meeting: 2018 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 2439

A Description of Contraception Practices in the Ohio State University Lupus Cohort

9:00AM-11:00AM: Abstract Number: 2427

Adequate Vaccine Response According to the Italian Schedule Among the Offspring of Women Affected By Rheumatoid Arthritis and Treated throughout Pregnancy By Certolizumab Pegol: Case Series

9:00AM-11:00AM: Abstract Number: 2437

Analysis of Occurrence of Small for Gestational Age Infants in Women with Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 2418

Awareness of Fertility and Contraception Issues Among Women with Rheumatologic Diseases

9:00AM-11:00AM: Abstract Number: 2431

Birth Outcomes and Disease Activity during Pregnancy in a Prospective Cohort of Women with Psoriatic Arthritis and Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 2423

Births to Women with Systemic Lupus Erythematosus Can be Identified Accurately in the Electronic Health Record

9:00AM-11:00AM: Abstract Number: 2424

Bisphosphonates during Pregnancy: A Systematic Review Sayanika Kaur MD Fellow Drexel Rheumatology, Mojdeh Khaamesi MD Resident Internal Medicine Arundathi Jayatilleke MD Program Director Drexel Rheumatology

9:00AM-11:00AM: Abstract Number: 2428

Correlation between Antibodies to the Phosphotidylserine/Prothrombin Complex (aPS/PT) and Anti-β2glycoprotein-1-Domain 1 (anti-β2GP1-D1) and Vascular Thrombosis (VT) and/or Pregnancy Morbidity (PM)

9:00AM-11:00AM: Abstract Number: 2426

Defining a Standardized Core Data Set for Pregnancy Registers in Rheumatic Diseases – an European Approach

9:00AM-11:00AM: Abstract Number: 2412

Evaluating Gaps in Reproductive Health Knowledge Among Women with Rheumatic Diseases

9:00AM-11:00AM: Abstract Number: 2442

Familial Mediterranean Fever Associated Infertility and Underlying Factors with Fertility

9:00AM-11:00AM: Abstract Number: 2416

Good Pregnancy and Neonatal Outcomes in Lupus Nephritis Patients with Complete Remission

9:00AM-11:00AM: Abstract Number: 2415

Increased Sperm DNA Fragmentation in Male Systemic LUPUS Erythematosus Patients

9:00AM-11:00AM: Abstract Number: 2429

Long-Term Outcome of Children Born to Mothers with Chronic Arthritis and Exposed to TNF-Inhibitors during Pregnancy: A Case-Control Study

9:00AM-11:00AM: Abstract Number: 2441

Needs and Barriers to Pregnancy Counselling in Women with SLE

9:00AM-11:00AM: Abstract Number: 2419

Needs Assessment and Implementation of a Reproductive Health Intention Screen for Women with Systemic Rheumatic Diseases

9:00AM-11:00AM: Abstract Number: 2434

Obstetric Outcomes in Women with Takayasu Arteritis: Results from Nationwide Inpatient Sample Database 2003-2011

9:00AM-11:00AM: Abstract Number: 2440

Outcomes of Pregnancy Complicated By ANCA-Associated Vasculitis: A Retrospective Review

9:00AM-11:00AM: Abstract Number: 2432

Peripartum Issues in the Inflammatory Arthritis (IA) Patient: A Survey of the Rapport (Rheumatoid Arthritis Pharmacovigilence Program and Outcomes Research in New Therapies) Registry

9:00AM-11:00AM: Abstract Number: 2430

Pregnancy in Women with Ankylosing Spondylitis Is Not Associated with Poor Obstetric Outcomes: Analysis of Nationwide Inpatient Sample Database 2003-2011

9:00AM-11:00AM: Abstract Number: 2420

Pregnancy Outcome and Perinatal Complications of Neonate Born to Mothers with Juvenile Idiopathic Arthritis in Asia

9:00AM-11:00AM: Abstract Number: 2435

Pregnancy Outcomes Among Women with Rare Autoimmune Diseases

9:00AM-11:00AM: Abstract Number: 2413

Pregnancy Outcomes in Mixed Connective Tissue Disease: Results from a Multicentre Cohort Study

9:00AM-11:00AM: Abstract Number: 2422

Pregnancy Outcomes in Patients with Interstitial Lung Disease Related to Autoimmune Disease and Sarcoidosis

9:00AM-11:00AM: Abstract Number: 2417

Pregnancy Outcomes in Systemic Lupus Erythematous and Pre-Systemic Lupus Erythematous: A Population-Based Cohort Study

9:00AM-11:00AM: Abstract Number: 2433

Pregnancy Outcomes in Undifferentiated Connective Tissue Disease- a Single Academic Center’s Experience

9:00AM-11:00AM: Abstract Number: 2421

Pregnancy Outcomes in Women with Rheumatic Diseases and Thrombophilia Treated in a Multidisciplinary Unit

9:00AM-11:00AM: Abstract Number: 2438

Risk and Severity of Adverse Pregnancy Outcomes in Women with Systemic Sclerosis in Taiwan

9:00AM-11:00AM: Abstract Number: 2414

The Global Antiphospholipid Syndrome Score in Women with Systemic Lupus Erythematosus and Adverse Pregnancy Outcomes

9:00AM-11:00AM: Abstract Number: 2425

The Impact of Biologic Treatment for Rheumatoid Arthritis Patients Who Hope to Conceive

9:00AM-11:00AM: Abstract Number: 2436

The Impact of Different Classes of Lupus Nephritis on Maternal and Fetal Outcomes

9:00AM-11:00AM: Abstract Number: 2411

The Ovarian Reserve Measuring the Anti-Müllerian Hormone Is Not Diminished in Patients with Rheumatoid Arthritis Compared to the Healthy Population

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].